Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
The Resverlogix and Amarin FDA meetings are completely unrelated, for different purposes, and scheduled way in advance. Coincidence, that is all. Today is the Advisory Committee meeting, not the PDUFA date, for Amarin's Vascepa. PDUFA date to decide on the approval of the sNDA for Vascepa isn't until Dec 28.
